DOUGLAS RICHARD
Insider CIK 1021015 · NVAX Director · MXCT Director · ALDX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NVAX NOVAVAX INC | M Exercise deriv | 2026-06-20 | 2026-06-23 | 18,880 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2026-06-20 | 2026-06-23 | 18,880 | — | $0 | 73,220 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2026-06-18 | 2026-06-23 | 14,180 | — | $0 | 14,180 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2026-06-18 | 2026-06-23 | 21,270 | — | $0 | 21,270 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2026-06-17 | 2026-06-22 | 49,579 | — | $0 | 49,579 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award | 2026-06-17 | 2026-06-22 | 30,421 | — | $0 | 260,998 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 2,323 | — | $0 | 2,323 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 70,000 | — | $0 | 70,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 19,909 | — | $0 | 19,909 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2026-03-19 | 2026-03-20 | 70,000 | $1.40 | $98.0K | 195,000 | SEC↗ |
| MXCT MAXCYTE, INC. | P Buy | 2025-08-13 | 2025-08-13 | 80,000 | $1.39 | $111.2K | 230,577 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2025-06-20 | 2025-06-24 | 28,326 | $6.42 | $181.9K | 28,326 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2025-06-20 | 2025-06-24 | 18,884 | — | $0 | 18,884 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2025-06-18 | 2025-06-23 | 50,790 | — | $0 | 50,790 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award | 2025-06-18 | 2025-06-23 | 29,210 | — | $0 | 150,577 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2025-06-12 | 2025-06-13 | 10,420 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2025-06-12 | 2025-06-13 | 10,420 | — | $0 | 54,340 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 1,689 | — | $0 | 1,689 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 14,476 | — | $0 | 14,476 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 62,728 | — | $0 | 62,728 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2024-06-12 | 2024-06-14 | 10,420 | — | $0 | 10,420 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2024-06-12 | 2024-06-14 | 15,630 | $15.86 | $247.9K | 15,630 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2024-06-12 | 2024-06-14 | 6,670 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2024-06-12 | 2024-06-14 | 6,670 | — | $0 | 43,920 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2024-06-11 | 2024-06-13 | 40,701 | — | $0 | 40,701 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award | 2024-06-11 | 2024-06-13 | 21,367 | — | $0 | 121,367 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2024-06-04 | 2024-06-06 | 40,282 | — | $0 | 40,282 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2024-06-04 | 2024-06-06 | 10,418 | — | $0 | 10,418 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2024-06-04 | 2024-06-06 | 1,215 | — | $0 | 1,215 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2023-06-30 | 2023-07-05 | 5,488 | — | $0 | 5,488 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2023-06-30 | 2023-07-05 | 21,222 | — | $0 | 21,222 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2023-06-30 | 2023-07-05 | 640 | — | $0 | 640 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2023-06-22 | 2023-06-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2023-06-12 | 2023-06-13 | 6,670 | — | $0 | 6,670 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2023-06-12 | 2023-06-13 | 7,710 | — | $0 | 7,710 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2023-06-10 | 2023-06-13 | 3,100 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2023-06-10 | 2023-06-13 | 3,100 | — | $0 | 37,250 | SEC↗ |
| MXCT MAXCYTE, INC. | P Buy | 2023-03-29 | 2023-03-30 | 80,000 | $4.32 | $345.6K | 100,000 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2022-06-29 | 2022-07-08 | 26,900 | — | $0 | 26,900 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2022-06-17 | 2022-06-21 | 700 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2022-06-17 | 2022-06-21 | 700 | — | $0 | 34,150 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2022-06-10 | 2022-06-14 | 4,600 | — | $0 | 4,600 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2022-06-10 | 2022-06-14 | 3,100 | — | $0 | 3,100 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2022-06-07 | 2022-06-09 | 1,624 | — | $0 | 1,624 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2022-06-07 | 2022-06-09 | 13,917 | — | $0 | 13,917 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2022-06-07 | 2022-06-09 | 53,812 | — | $0 | 53,812 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-12-13 | 2021-12-15 | 1,500 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-12-13 | 2021-12-15 | 1,500 | $25.60 | $38.4K | 33,450 | SEC↗ |
| MXCT MAXCYTE, INC. | P Buy | 2021-11-22 | 2021-11-23 | 20,000 | $11.12 | $222.4K | 20,000 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2021-08-09 | 2021-08-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2021-06-25 | 2021-06-29 | 3,450 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2021-06-25 | 2021-06-29 | 3,450 | — | $0 | 31,950 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2021-06-17 | 2021-06-22 | 700 | — | $0 | 700 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2021-06-17 | 2021-06-22 | 1,300 | — | $0 | 1,300 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2021-06-08 | 2021-06-10 | 408 | — | $0 | 408 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2021-06-08 | 2021-06-10 | 3,500 | — | $0 | 3,500 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2021-06-08 | 2021-06-10 | 13,534 | — | $0 | 13,534 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise deriv | 2020-12-31 | 2021-01-05 | 1,000 | — | $0 | 0 | SEC↗ |
| NVAX NOVAVAX INC | M Exercise | 2020-12-31 | 2021-01-05 | 1,000 | $50.00 | $50.0K | 28,500 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2020-06-25 | 2020-06-26 | 3,450 | — | $0 | 3,450 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2020-06-25 | 2020-06-26 | 6,900 | — | $0 | 6,900 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 26,503 | — | $0 | 26,503 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 9,245 | — | $0 | 9,245 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 1,079 | — | $0 | 1,079 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2020-03-16 | 2020-03-17 | 40,000 | $2.75 | $110.0K | 125,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2019-12-12 | 2019-12-16 | 18,000 | — | $0 | 18,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2019-09-13 | 2019-09-17 | 5,000 | $6.00 | $30.0K | 85,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2019-09-12 | 2019-09-13 | 10,000 | $6.03 | $60.3K | 80,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2019-09-11 | 2019-09-13 | 10,000 | $5.75 | $57.5K | 70,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2019-09-10 | 2019-09-11 | 10,000 | $5.09 | $50.9K | 60,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2019-09-09 | 2019-09-11 | 10,000 | $4.91 | $49.1K | 50,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2019-06-04 | 2019-06-06 | 18,951 | — | $0 | 18,951 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2019-06-04 | 2019-06-06 | 6,611 | — | $0 | 6,611 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2019-06-04 | 2019-06-06 | 771 | — | $0 | 771 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2018-12-13 | 2018-12-14 | 90,000 | — | $0 | 90,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2018-06-07 | 2018-06-08 | 5,416 | — | $0 | 5,416 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2018-06-07 | 2018-06-08 | 15,526 | — | $0 | 15,526 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2018-06-07 | 2018-06-08 | 632 | — | $0 | 632 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2017-12-15 | 2017-12-19 | 80,000 | — | $0 | 80,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2017-06-08 | 2017-06-12 | 1,037 | — | $0 | 1,037 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2017-06-08 | 2017-06-12 | 17,776 | — | $0 | 17,776 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2017-06-08 | 2017-06-12 | 8,888 | — | $0 | 8,888 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2017-05-11 | 2017-05-12 | 200,000 | $0.93 | $186.0K | 550,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2017-03-16 | 2017-03-20 | 80,000 | — | $0 | 80,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2017-02-17 | 2017-02-21 | 40,000 | $4.50 | $180.0K | 40,000 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2016-09-21 | 2016-09-22 | 100,000 | $1.72 | $172.0K | 350,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2016-09-13 | 2016-09-14 | 12,166 | — | $0 | 12,166 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2016-03-15 | 2016-03-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2015-03-05 | 2015-03-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2014-03-25 | 2014-03-25 | 50,000 | $4.33 | $216.5K | 250,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2014-03-06 | 2014-03-07 | 30,000 | — | $0 | 130,000 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2013-06-12 | 2013-06-13 | 50,000 | $1.90 | $95.0K | 200,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2013-03-02 | 2013-03-06 | 30,000 | $1.83 | $54.9K | 100,000 | SEC↗ |
| NVAX NOVAVAX INC | P Buy | 2012-04-10 | 2012-04-11 | 50,000 | $1.21 | $60.5K | 200,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2012-03-01 | 2012-03-08 | 20,000 | $1.28 | $25.6K | 60,000 | SEC↗ |